Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | — | 135.3B | 114.9B | 108.9B |
Cost of revenue | — | 108.7B | 92.8B | 89.3B |
Gross profit | — | 26.6B | 22.1B | 19.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | — | 10.1B | 7.1B | 2.6B |
Non operating interest income | ||||
Income | — | 119M | 118M | 61M |
Expense | — | 330M | 235M | 233M |
Other income expense | — | — | — | — |
Pretax income | — | 11.8B | 12.5B | 5.7B |
Tax provision | — | 2.5B | 1.6B | 366M |
Net income | — | 9.3B | 10.9B | 5.4B |
Basic EPS | 49.5 | — | — | — |
Diluted EPS | 49.5 | — | — | — |
Basic average shares | 97.1M | — | — | — |
Diluted average shares | 97.1M | — | — | — |
EBITDA | — | 21.1B | 19.6B | 12.8B |
Net income from continuing op. | — | 11.8B | 12.5B | 5.7B |
Minority interests | — | -251M | 13M | 9M |
Preferred stock dividends | — | 0 | 0 | 0 |